The local medical sector is excited with the arrival of retatrutide, a innovative dual GIP and GLP-1 medication showing impressive results in early trials for treating obesity. This treatment suggests a https://auresortwear.com/2026/06/10/retatrutide-australia-my-deep-dive-into-weight-loss-treatments/